Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : TATRADER GIZZARD STUDY--Stocks 12.00 or Less..... -- Ignore unavailable to you. Want to Upgrade?

To: Willsgarden who wrote (54539)	4/7/2006 10:00:56 AM
From: lexi2004	Respond to of 59879

NVAX...Could those shorts be making my day? Would believe this could be one short squeeze coming.:) BTW, I'm still holding my long shares. Lexi

To: Willsgarden who wrote (54539)	4/7/2006 10:42:50 AM
From: hotlinktuna	Respond to of 59879

Good Bill! I got ACDI here 2.98 w/target of 3.75 just recently: Dutton Associates Announces Investment Opinion: Arcadia Resources Buy Rating Maintained In Updated Initial Coverage By Dutton Associates Monday April 3, 12:06 pm ET EL DORADO HILLS, Calif.--(BUSINESS WIRE)--April 3, 2006--Dutton Associates updates its coverage of Arcadia Resources (OTCBB:ACDI - News) maintaining a Buy rating and a $3.75 price target. The 10-page report by Dutton senior analyst David Riedel is available at www.jmdutton.com as well as from First Call, Bloomberg, Zacks, Reuters, Knobias, and other leading financial portals. ADVERTISEMENT Arcadia Resources, Inc., is rapidly growing into a national player in two of the most attractive areas in the medical field: health care staffing (including home care) and durable medical equipment (DME). Recent progress on initiatives to sell home healthcare products through Sears stores and catalogs are, we believe, a smart strategic move by the Company. Still largely a services (i.e. staffing) company, the Company is increasing its exposure to higher-margin product sales, resulting in better margins and a brighter profit outlook. While near-term earnings projections are modest, we believe conditions at Arcadia will improve markedly in 2006 and patient investors will be rewarded for the reasons we discuss in our report. About Dutton Associates Dutton Associates is one of the largest independent investment research firms in the U.S. Its 29 senior analysts are primarily CFAs and have expertise in many industries. Dutton Associates provides continuing analyst coverage of over 120 enrolled companies, and its research, estimates, and ratings are carried in all the major databases serving institutions and online investors. The cost of enrollment in our one-year continuing research program is US $35,000 prepaid for 4 Research Reports, typically published quarterly, and requisite Research Notes. Dutton Associates received $63,000 from the Company for 8 Research Reports with coverage commencing on 10/29/2004. We do not accept payment of our fees in company stock. Our principals and analysts are prohibited from owning or trading in securities of covered companies. The views expressed in this research report accurately reflect the analyst's personal views about the subject securities or issuer. Neither the analyst's compensation nor the compensation received by us is in any way related to the specific ratings or views contained in this research report or note. Please read full disclosures and analyst background at www.jmdutton.com before investing. Contact: Dutton Associates John M. Dutton, 916-941-8119 -------------------------------------------------------------------------------- Source: Arcadia Resources, Inc.